Jump to content

Dora Mbanya

From Wikipedia, the free encyclopedia
Dora Ngum Shu Mbanya
Born
Dora Ngum Shu

(1956-12-13) 13 December 1956 (age 67)
Northwest, Cameroon, West Africa
Citizenship Cameroon
Alma mater
Known foridentification of a new subgenotype of hepatitis b virus (a3), hepatitis delta and c strains.
SpouseJean Claude Mbanya
Scientific career
FieldsBlood transfusion medicine and clinical use of blood.
Institutions

Dora Ngum Shu Mbanya (born 13 December 1956) is a Cameroonian Professor of Haematology at the University of Yaoundé I (UYI) and the head of the Cameroon branch of Africa Society for Women and Aids in Africa.[1][2][3][4][5]

Biography

[edit]

Dora Mbanya was born on 13 December 1956 in the North West region of Cameroon. She is a physician and specialises in haematology.[6] She obtained a medical degree in General Medicine from cameroon and bagged her PhD in Medicine/Haematology from Newcastle upon Tyne, England. She holds a Dîplome Universitaire in Transfusion Medicine from the Université d’Abidjan, Côte d’Ivoire. She is also the General Manager of the National Blood Transfusion Service in Cameroon and the president of Africa Society for Blood Transfusion. She is married to another professor of Medicine and Endocrinology, Jean Claude Mbanya.[1][7][5]

Research interests

[edit]

Dora Mbaya focused on blood transfusion medicine, clinical use of blood; transfusion-transmissible infections (TTIs) like hepatitis B, C, Syphilis, and HIV.[1]

Scientific contributions

[edit]

Dora and her team was able identify a new subgenotype of hepatitis b virus (a3), hepatitis delta and c strains. they also identified the horizontal transmission of the group n, hiv-1 and an hiv-2 intergroup recombinant strain. In their work, they proved that primary drug resistance in drug-naïve HIV-infected people, and illustrated widely the HIV-1 genetic diversity in Cameroon. These contributions have led to the production of diagnostics assays for detecting diverse HIV strains in clinical specimens.[1]

Selected publications

[edit]
  • Mbanya, Dora; Binam, Fidele; Kaptue, Lazare (2001-01-01): Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation: [8]
  • Mbanya, Dora; Ateudjieu, Jerome; Tagny, Claude Tayou; Moudourou, Sylvie; Lobe, Marcel Monny; Kaptue, Lazare (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon[9]
  • Anye, Angwafor; Tasha, Ngwanui; Njamnshi, Alfred; Mbanya, Dora: Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon[10]
  • Mbanya, Dora: Barriers and enablers to introducing comprehensive patient blood management in the hospital[11]
  • Tagny, Claude Tayou; Mbanya, Dora; Murphy, Edward L.; Lefrère, Jean-Jacques; Laperche, Syria: Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test[12]
  • Mbanya, Dora Ngum; Zebaze, Roger; Minkoulou, Etienne-Magloire; Binam, Fidele; Koulla, Sinata; Obounou, Akong: Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective[13]
  • Mbanya, Dora; Assah, Felix; Ndembi, Nicaise; Kaptue, Lazare: Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? [14]

References

[edit]
  1. ^ a b c d "Dora Mbanya | The AAS". www.aasciences.africa. Archived from the original on 2022-12-31. Retrieved 2023-02-06.
  2. ^ "Dora Mbanya – AfSBT". Retrieved 2023-02-06.
  3. ^ Press, Dove. "Professor DN Mbanya | Dove Press editor profile". www.dovepress.com. Retrieved 2023-02-06.
  4. ^ ISBT. "The 4th AfSBT Educational Webinar". www.isbtweb.org. Retrieved 2023-02-06.
  5. ^ a b "Professor Dora Mbanya : Haematologist For Community's Welfare". www.cameroon-tribune.cm. Retrieved 2023-02-06.
  6. ^ "Professor Dora Mbanya : Haematologist For Community's Welfare". www.cameroon-tribune.cm. Retrieved 2023-02-07.
  7. ^ echosante (2021-05-04). "Blood Transfusion – Prof. Dora Mbanya Urges Cameroonians To Save Lives Through Blood Donation". Echos Santé (in French). Retrieved 2023-02-07.
  8. ^ Mbanya, Dora; Binam, Fidele; Kaptue, Lazare (2001-01-01). "Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation". International Journal of Infectious Diseases. 5 (2): 70–73. doi:10.1016/S1201-9712(01)90028-1. ISSN 1201-9712. PMID 11468100.
  9. ^ Mbanya, Dora; Ateudjieu, Jerome; Tagny, Claude Tayou; Moudourou, Sylvie; Lobe, Marcel Monny; Kaptue, Lazare (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon". International Journal of Environmental Research and Public Health. 7 (5): 2085–2100. doi:10.3390/ijerph7052085. PMC 2898038. PMID 20623013.
  10. ^ Anye, Angwafor; Tasha, Ngwanui; Njamnshi, Alfred; Mbanya, Dora (2021-10-01). "Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon". Journal of the Neurological Sciences. Abstracts from the World Congress of Neurology (WCN 2021). 429: 118934. doi:10.1016/j.jns.2021.118934. ISSN 0022-510X. S2CID 238427596.
  11. ^ Mbanya, Dora (2012-05-01). "Barriers and enablers to introducing comprehensive patient blood management in the hospital". Biologicals. Proceedings of the 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety. 40 (3): 205–208. doi:10.1016/j.biologicals.2012.01.003. ISSN 1045-1056. PMID 22316645.
  12. ^ Tagny, Claude Tayou; Mbanya, Dora; Murphy, Edward L.; Lefrère, Jean-Jacques; Laperche, Syria (2014-04-01). "Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test". Journal of Virological Methods. 199: 119–123. doi:10.1016/j.jviromet.2014.01.002. ISSN 0166-0934. PMC 5042449. PMID 24487098.
  13. ^ Mbanya, Dora Ngum; Zebaze, Roger; Minkoulou, Etienne-Magloire; Binam, Fidele; Koulla, Sinata; Obounou, Akong (2002-06-01). "Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective". International Journal of Infectious Diseases. 6 (2): 134–138. doi:10.1016/S1201-9712(02)90075-5. ISSN 1201-9712. PMID 12121602.
  14. ^ Mbanya, Dora; Assah, Felix; Ndembi, Nicaise; Kaptue, Lazare (2007-03-01). "Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?". International Journal of Infectious Diseases. 11 (2): 157–160. doi:10.1016/j.ijid.2006.02.008. ISSN 1201-9712. PMID 16762583.